LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. announced today the appointment of Mark Roessel to Vice President of Regulatory Affairs and Quality Assurance and LuAnn Sabounjian to Vice President, Clinical Operations. Both Mr. Roessel and Ms. Sabounjian are appointed to key roles in expanding Concert’s development pipeline and will report to Dr. James Shipley, Concert’s Chief Medical Officer.
